Screener
aTyr Pharma ATYR Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from aTyr Pharma’s reported figures.
Based on the most recent quarter.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's debt-to-equity?
- aTyr Pharma (ATYR) reported debt-to-equity of 0.2× in Q2 2026.
- How has aTyr Pharma's debt-to-equity changed year-over-year?
- aTyr Pharma's debt-to-equity increased by 36.9% year-over-year, from 0.2× to 0.2×.
- What is the long-term trend for aTyr Pharma's debt-to-equity?
- Over 5 years (2020 to 2025), aTyr Pharma's debt-to-equity has grown at a 21.6% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about aTyr Pharma's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude